CRISPR/Cas9

被引:4
|
作者
Mizuno, Naoaki [1 ]
Mizutani, Eiji [1 ]
Sato, Hideyuki [1 ]
Kasai, Mariko [1 ]
Nakauchi, Hiromitsu [1 ,2 ]
Yamaguchi, Tomoyuki [1 ]
机构
[1] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Minato Ku, Tokyo, Japan
[2] Stanford Univ, Sch Med, Dept Genet, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA
来源
BIO-PROTOCOL | 2019年 / 9卷 / 13期
关键词
CRISPR/Cas9; Adeno-associated viral vector; Trans-zona pellucida; Intra-embryo genome editing; Ribonucleoprotein electroporation; Large fragment knock-in; ELECTROPORATION;
D O I
10.21769/BioProtoc.3295
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intra-embryo genome editing by CRISPR/Cas9 has enabled rapid generation of gene knockout animals. However, large fragment knock-in directly into embryos' genome is still difficult, especially without microinjection of donor DNA. Viral vectors are good transporters of knock-in donor DNA for cell lines, but seemed unsuitable for pre-implantation embryos with zona pellucida, glycoprotein membrane surrounding early embryos. We found adeno-associated virus (AAV) can infect zygotes of various mammals through intact zona pellucida. AAV-mediated donor DNA delivery following Cas9 ribonucleoprotein electroporation enables large fragment knock-in without micromanipulation.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Bets Placed On CRISPR/Cas9
    Thayer, Ann
    CHEMICAL & ENGINEERING NEWS, 2015, 93 (48) : 16 - 16
  • [32] Genome modification by CRISPR/Cas9
    Ma, Yuanwu
    Zhang, Lianfeng
    Huang, Xingxu
    FEBS JOURNAL, 2014, 281 (23) : 5186 - 5193
  • [33] The tsunami named CRISPR/Cas9
    Chneiweiss, H.
    REVUE NEUROLOGIQUE, 2018, 174 (7-8) : 487 - 488
  • [34] Anything impossible with CRISPR/Cas9?
    Renjie Jiao
    Caixia Gao
    Science China(Life Sciences), 2017, 60 (05) : 445 - 446
  • [35] Liposomal delivery of CRISPR/Cas9
    Shuai Zhen
    Xu Li
    Cancer Gene Therapy, 2020, 27 : 515 - 527
  • [36] MicroRNAs tame CRISPR–Cas9
    Karina Jouravleva
    Phillip D. Zamore
    Nature Cell Biology, 2019, 21 : 416 - 417
  • [37] Improving the efficiency of Cas9/CRISPR genome engineering by optimizing Cas9 delivery
    Pelczar, Pawel
    Oller, Heide
    Kornete, Mara
    Schreiner, Dietmar
    Hermann, Mario
    Jeker, Lukas
    TRANSGENIC RESEARCH, 2016, 25 (02) : 255 - 256
  • [38] The CRISPR/Cas9 Genome Editing Revolution
    Renjie Jiao
    Caixia Gao
    Journal of Genetics and Genomics, 2016, 43 (05) : 227 - 228
  • [39] Conditional Control of CRISPR/Cas9 Function
    Zhou, Wenyuan
    Deiters, Alexander
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (18) : 5394 - 5399
  • [40] CRISPR/Cas9 and the future of clinical research
    Hampshire, Victoria
    LAB ANIMAL, 2016, 45 (03) : 89 - 90